Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 766 to 780 of 1455 results for do not do recommendations

  1. Practitioners and providers' awareness of risk in black, Asian and other minority ethnic groups: Are clinicians, practitioners and weight management service providers aware that black, Asian and other minority ethnic groups are at the same risk of type 2 diabetes and mortality at a lower BMI compared with the white population. If so, do they intervene at lower BMI and waist-to-height ratio thresholds?

    Recommendation ID CG189/11 Question Practitioners and providers' awareness of risk in black, Asian and other minority ethnic groups: Are

    Research recommendation
    Published
    30 September 2022

  2. How effective and cost effective are different types of intervention to prevent a range of cold-related illnesses and death? How do these vary with groups in different circumstances?

    Recommendation ID NG6/3 Question How effective and cost effective are different types of intervention to prevent a range of cold-related

    Research recommendation
    Published
    9 June 2015

  3. Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency (HST26)

    Evidence-based recommendations on eladocagene exuparvovec (Upstaza) for treating aromatic L-amino acid decarboxylase deficiency in people 18 months and over.

    Highly specialised technologies guidance
    Published
    19 April 2023
    View recommendations

    Sections for HST26

  4. Individual circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to alternative sources of support lead to an increased risk of problems associated with dependence on prescribed medicines?

    Recommendation ID NG215/04 Question Individual circumstances and the risk of dependence: Do individual circumstances such...

    Research recommendation
    Published
    11 May 2022

  5. System-level factors and the risk of dependence: Do system-level factors, such as training received by prescribers alter the risk of developing problems associated with dependence on prescribed medicines?

    Recommendation ID NG215/06 Question System-level factors and the risk of dependence: Do system-level factors, such as...

    Research recommendation
    Published
    11 May 2022

  6. Further research is recommended on alternative postpartum testing strategies that do not include cord blood typing of all babies born to rhesus-D (D) negative women.

    Recommendation ID DG25/1 Question Further research is recommended on alternative postpartum testing strategies that do not...

    Research recommendation
    Published
    10 February 2017

  7. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation

  8. Reducing demands on health and social care services:- Do preventive oral health interventions in residential and nursing care homes reduce demands on other health and social care services?

    Recommendation ID NG48/5 Question Reducing demands on health and social care services:- Do preventive oral health...

    Research recommendation
    Published
    24 August 2016

  9. Ravulizumab for treating paroxysmal nocturnal haemoglobinuria (TA698)

    Evidence-based recommendations on ravulizumab (Ultomiris) for treating paroxysmal nocturnal haemoglobinuria in adults.

    Technology appraisal guidance
    Published
    19 May 2021
    View recommendations

    Sections for TA698

  10. Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency (TA709)

    Evidence-based recommendations on pembrolizumab (Keytruda) for treating metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency in adults.

    Technology appraisal guidance
    Published
    23 June 2021
    View recommendations

    Sections for TA709

  11. What interventions are effective to support medicines adherence for people with complex psychosis in supported accommodation?

    Recommendation ID NG181/9 Question What interventions are effective to support medicines adherence for people with complex psychosis in

    Research recommendation
    Published
    26 October 2020

  12. Further research is recommended on:• the impact of magnetic resonance elastography (MRE) test results on decisions about care, such as the decision to do a liver biopsy, or on adherence to lifestyle interventions (see section 3.5 )• the test accuracy of MRE to assess the level of fibrosis or presence of cirrhosis compared with biopsy at thresholds specified by the company, or the prognostic ability of MRE to predict clinical outcomes (see section 3.20 ).

    Recommendation ID DG50/02 Question Further research is recommended on:• the impact of magnetic resonance elastography (MRE) test results

    Research recommendation
    Published
    3 February 2023

  13. Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)

    NICE has developed a medtech innovation briefing (MIB) on Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions .

    Medtech innovation briefing
    Published
    29 November 2016

  14. Information needs for children and young people:- during their care pathway to diagnosis of food allergy:- What do children and young people with IgE-mediated food allergy and their parents or carers want to know during the process of diagnosis and how is this demand best met?

    Recommendation ID CG116/3 Question Information needs for children and young people:- during their care pathway to diagnosis of food...

    Research recommendation
    Published
    9 June 2015

  15. At what gestation should treatment with prophylactic vaginal progesterone for the prevention of preterm birth be started and stopped?

    Recommendation ID NG25/7 Question At what gestation should treatment with prophylactic vaginal progesterone for the prevention of preterm

    Research recommendation
    Published
    25 October 2019